Raloxifene for Women With Alzheimer's Disease

Trial ID or NCT#

NCT00368459

Status

not recruiting iconNOT RECRUITING

Purpose

This is a multisite pilot randomized trial of raloxifene or placebo for the treatment of women with Alzheimer's disease.

Official Title

Raloxifene in Women With AD: Randomized Controlled Trial

Eligibility Criteria

Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: No
Show Less

Contact us to find out if this trial is right for you.

Contact

Narinder Bolaria
6507313308

View on ClinicalTrials.gov